Status:
COMPLETED
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Lead Sponsor:
Florida State University
Conditions:
Parkinson's Disease
Multiple Sclerosis
Eligibility:
All Genders
45-90 years
Phase:
NA
Brief Summary
Fatigue is one of the most common and debilitating symptoms experienced in Parkinson's Disease (PD) and Multiple Sclerosis (MS). There are multiple proposed mechanisms of disorder-related fatigue, how...
Detailed Description
Patients diagnosed with Parkinson's Disease (PD) and Multiple Sclerosis (MS) frequently experience increased levels of muscle weakness and fatigue; This impairment is exacerbated with onset of exercis...
Eligibility Criteria
Inclusion
- Parkinson's Disease Stage I-IV (be standard criteria H\&Y scale)
- Multiple Sclerosis
- Healthy, age-matched controls
- 45 to 90 years old
Exclusion
- Dementia
- Co-morbid neurologic factors
- Individuals without independent ambulation
- Significant heart and respiratory disease
- Debilitating arthritis
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT02184494
Start Date
August 1 2014
End Date
December 1 2014
Last Update
March 30 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fitness and Wellness Center
Tallahassee, Florida, United States, 32306
2
Balance Disorders Clinic
Tallahassee, Florida, United States, 32308